Product fact sheet

Hooga PRO4500 Technical Profile

Name: Hooga PRO4500
Brand: Hooga

Hooga PRO4500 specifications include a 61.2 × 15.7 × 3.1 inch panel, 900 dual-chip LEDs, 660/850 nm output, 4500 W nominal lamp power and 1200 W listed consumption.

Red-light therapy guideReturn to the therapy guide and compare device specifications in context. Compare in context → Red-light panel comparisonOpen the comparison surface for this product family; missing comparable data is shown rather than guessed. Compare products →

Desk researchedFacts checked 2026-08-11

A wide 900-LED two-wavelength PRO-series panel with a current manual listing 1200 W electrical consumption and a 61.2 × 15.7 inch face.

Fit signals

large-panel hardware comparisons, buyers auditing power and footprint from a primary manual

Potential constraints

buyers needing independent optical-output data, small-space setups

Key tradeoff: The hardware record is detailed, but manufacturer irradiance charts are not independent verification.

This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.

Technical record

The 2025 PRO-series manual lists the PRO4500 at 61.2 × 15.7 × 3.1 inches, with 900 × 5 W dual-chip LEDs, 660 nm and 850 nm wavelengths and a 60° beam angle. Its table separates a 4500 W nominal lamp-power label from 1200 W listed electrical consumption.

What the larger format changes

A larger emitter field changes footprint, mounting and electrical-load considerations. It does not establish a larger delivered dose or a better clinical result by itself. Coverage, optical uniformity, working distance and protocol still matter, and the 1200 W consumption figure is distinct from the 4500 W nominal lamp-power label.

Evidence boundary

No compatible independent common-protocol irradiance measurement is available for this model in the current record. Installation, thermal, acoustic and electrical-load observations are also not available, so those quantities should not be inferred from manufacturer marketing.

Technical specifications

Published specs and what they mean

Physical

Dimensions: 61.2 × 15.7 × 3.1 in

Optical

Wavelengths: 660 / 850 nm
LED quantity: 900 × 5 W dual-chip LEDs
Lamp power rating: 4500 W
Beam angle: 60°

Electrical

Power consumption: 1200 W
Power input: AC 85–265 V

Environment

Operating temperature: 32–90°F

What the current record does not establish

No independent common-protocol optical measurement is normalized.
No Homeapotherapy installation, noise, heat or electrical-load testing exists.
Large-panel usability cannot be inferred from dimensions alone.

A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.

Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.

Dose and irradiance context

What the output number means over time

Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.

No comparable independent average irradiance is normalized

This device may have a manufacturer-published irradiance claim, but Homeapotherapy does not calculate time-to-fluence from that number unless the current record contains a sufficiently defined independent area-average measurement. This avoids presenting unlike measurement methods as interchangeable.

What this calculation still cannot tell you

whether this is an effective dose for any condition;
how irradiance changes at a different distance or across curved anatomy;
how much energy reaches tissue below the surface;
whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
whether peak irradiance would produce the same area exposure as the average value shown here.

Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.

Clinical evidence context

Where these wavelengths overlap with human research

Published device wavelengths: 660 / 850 nm.

This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.

Research areas worth checking

Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.

Do not infer from wavelength overlap

that this device is clinically proven for the linked condition;
that more wavelengths are better;
that the highest published irradiance is the best dose;
that an open wound should be treated with a consumer device without appropriate wound assessment.

For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.

Safety first

What should make you slow down?

Large-panel power, installation and eye-safety requirements should be checked against the current manufacturer manual before use.

The PRO-series manual contains electrical and eye-exposure warnings.
Large physical coverage does not itself establish dose uniformity or clinical effectiveness.

Where to buy

Current tracked merchants

Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.

No merchant destination is currently tracked for this product.

Source trail

Primary documents and supporting evidence

Hooga PRO Series User ManualHooga · Manufacturer manual · PDF · retrieved 2026-08-11
Hooga Quality & Certifications: What We Can VerifyHooga · Manufacturer · retrieved 2026-08-10
Photobiomodulation (PBM) Devices - Premarket Notification [510(k)] SubmissionsU.S. Food and Drug Administration · Regulatory · retrieved 2026-08-10

Comparable products